153 related articles for article (PubMed ID: 8289526)
1. [A cost-effectiveness analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].
Tebas P
Med Clin (Barc); 1993 Dec; 101(19):757-8. PubMed ID: 8289526
[No Abstract] [Full Text] [Related]
2. [A cost-efficacy analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].
Badía X; Segú L; García Alonso F; Rovira J
Med Clin (Barc); 1993 Jan; 100(3):84-9. PubMed ID: 8426499
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients.
Chalfin DB; Holbein ME; Fein AM; Carlon GC
JAMA; 1993 Jan; 269(2):249-54. PubMed ID: 8417245
[TBL] [Abstract][Full Text] [Related]
4. Antiendotoxin monoclonal antibodies for gram-negative sepsis.
Chmel H; Emmanuel G
Clin Infect Dis; 1992 Aug; 15(2):371-2. PubMed ID: 1520771
[No Abstract] [Full Text] [Related]
5. Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA.
Wenzel RP; Andriole VT; Bartlett JG; Batt MD; Bullock WE; Cobbs CG; Light B; Martin MA; Sanford J; Sande MA
Clin Infect Dis; 1992 Apr; 14(4):973-6. PubMed ID: 1482434
[No Abstract] [Full Text] [Related]
6. Antibody to endotoxin in the treatment of gram-negative sepsis.
Schentag JJ
JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766
[No Abstract] [Full Text] [Related]
7. Monoclonal antibodies to endotoxin in the management of sepsis.
Fang KC
West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
[TBL] [Abstract][Full Text] [Related]
8. Antibody to endotoxin in the treatment of gram-negative sepsis.
Spalter J
JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764
[No Abstract] [Full Text] [Related]
9. Antibody to endotoxin in the treatment of gram-negative sepsis.
McCabe WR
JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
[No Abstract] [Full Text] [Related]
10. Antibody to endotoxin in the treatment of gram-negative sepsis.
van Deventer S
JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
[No Abstract] [Full Text] [Related]
11. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
Barriere SL; Guglielmo BJ
Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
[TBL] [Abstract][Full Text] [Related]
12. Antiendotoxin antibodies.
Siegel JP
Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
[No Abstract] [Full Text] [Related]
13. Evaluating the cost containment potential of clinical guidelines.
Carpenter CE; Nash DB; Johnson NE
QRB Qual Rev Bull; 1993 Apr; 19(4):119-23. PubMed ID: 8493026
[TBL] [Abstract][Full Text] [Related]
14. Antiendotoxin antibodies: a dead end?
Cross AS
Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
[No Abstract] [Full Text] [Related]
15. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies for gram-negative sepsis.
Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976
[No Abstract] [Full Text] [Related]
17. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
Talan DA
Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
[TBL] [Abstract][Full Text] [Related]
18. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.
Hurley JC
Drugs; 1994 Jun; 47(6):855-61. PubMed ID: 7521827
[No Abstract] [Full Text] [Related]
19. Antiendotoxin monoclonal antibodies. What future now?
Susla GM; Dew RB
Drug Saf; 1994 Oct; 11(4):215-22. PubMed ID: 7848542
[No Abstract] [Full Text] [Related]
20. Projected impact of monoclonal anti-endotoxin antibody therapy.
Bates DW; Lee TH
Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]